These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 38917525)

  • 1. Repurposing metformin as adjuvant therapy in patients with ulcerative colitis treated with mesalamine: A randomized controlled double-blinded study.
    El-Haggar SM; Hegazy SK; Maher MM; Bahgat MM; Bahaa MM
    Int Immunopharmacol; 2024 Sep; 138():112541. PubMed ID: 38917525
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Targeting IL-10, ZO-1 gene expression and IL-6/STAT-3 trans-signaling by a combination of atorvastatin and mesalazine to enhance anti-inflammatory effects and attenuates progression of oxazolone-induced colitis.
    El-Mahdy NA; El-Sayad ME; El-Kadem AH; Abu-Risha SE
    Fundam Clin Pharmacol; 2021 Feb; 35(1):143-155. PubMed ID: 32383169
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Metformin alleviates inflammation in oxazolone induced ulcerative colitis in rats: plausible role of sphingosine kinase 1/sphingosine 1 phosphate signaling pathway.
    El-Mahdy NA; El-Sayad ME; El-Kadem AH; Abu-Risha SE
    Immunopharmacol Immunotoxicol; 2021 Apr; 43(2):192-202. PubMed ID: 33504231
    [TBL] [Abstract][Full Text] [Related]  

  • 4. N-acetyl-L-cysteine combined with mesalamine in the treatment of ulcerative colitis: randomized, placebo-controlled pilot study.
    Guijarro LG; Mate J; Gisbert JP; Perez-Calle JL; Marin-Jimenez I; Arriaza E; Olleros T; Delgado M; Castillejo MS; Prieto-Merino D; Gonzalez Lara V; Pena AS
    World J Gastroenterol; 2008 May; 14(18):2851-7. PubMed ID: 18473409
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Curcumin in Combination With Mesalamine Induces Remission in Patients With Mild-to-Moderate Ulcerative Colitis in a Randomized Controlled Trial.
    Lang A; Salomon N; Wu JC; Kopylov U; Lahat A; Har-Noy O; Ching JY; Cheong PK; Avidan B; Gamus D; Kaimakliotis I; Eliakim R; Ng SC; Ben-Horin S
    Clin Gastroenterol Hepatol; 2015 Aug; 13(8):1444-9.e1. PubMed ID: 25724700
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Direct comparison of two different mesalamine formulations for the induction of remission in patients with ulcerative colitis: a double-blind, randomized study.
    Ito H; Iida M; Matsumoto T; Suzuki Y; Sasaki H; Yoshida T; Takano Y; Hibi T
    Inflamm Bowel Dis; 2010 Sep; 16(9):1567-74. PubMed ID: 20049950
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Quantitive cytokine mRNA expression profiles in the colonic mucosa of patients with steroid naïve ulcerative colitis during active and quiescent disease.
    Matsuda R; Koide T; Tokoro C; Yamamoto T; Godai T; Morohashi T; Fujita Y; Takahashi D; Kawana I; Suzuki S; Umemura S
    Inflamm Bowel Dis; 2009 Mar; 15(3):328-34. PubMed ID: 18942752
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of Long-Term Mesalamine Therapy on Cancer-Associated Gene Expression in Colonic Mucosa of Patients with Ulcerative Colitis.
    Bajpai M; Seril DN; Van Gurp J; Geng X; Alvarez J; Minacapelli CD; Gorin S; Das KK; Poplin E; Cheng J; Amenta PS; Das KM
    Dig Dis Sci; 2019 Mar; 64(3):740-750. PubMed ID: 30478770
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mesalamine once daily is more effective than twice daily in patients with quiescent ulcerative colitis.
    Dignass AU; Bokemeyer B; Adamek H; Mross M; Vinter-Jensen L; Börner N; Silvennoinen J; Tan G; Pool MO; Stijnen T; Dietel P; Klugmann T; Vermeire S; Bhatt A; Veerman H
    Clin Gastroenterol Hepatol; 2009 Jul; 7(7):762-9. PubMed ID: 19375519
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Curcumin maintenance therapy for ulcerative colitis: randomized, multicenter, double-blind, placebo-controlled trial.
    Hanai H; Iida T; Takeuchi K; Watanabe F; Maruyama Y; Andoh A; Tsujikawa T; Fujiyama Y; Mitsuyama K; Sata M; Yamada M; Iwaoka Y; Kanke K; Hiraishi H; Hirayama K; Arai H; Yoshii S; Uchijima M; Nagata T; Koide Y
    Clin Gastroenterol Hepatol; 2006 Dec; 4(12):1502-6. PubMed ID: 17101300
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of extended MMX mesalamine therapy for acute, mild-to-moderate ulcerative colitis.
    Kamm MA; Lichtenstein GR; Sandborn WJ; Schreiber S; Lees K; Barrett K; Joseph R
    Inflamm Bowel Dis; 2009 Jan; 15(1):1-8. PubMed ID: 18671232
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A randomized, double blind, dose-response comparison of balsalazide (6.75 g), balsalazide (2.25 g), and mesalamine (2.4 g) in the treatment of active, mild-to-moderate ulcerative colitis.
    Levine DS; Riff DS; Pruitt R; Wruble L; Koval G; Sales D; Bell JK; Johnson LK
    Am J Gastroenterol; 2002 Jun; 97(6):1398-407. PubMed ID: 12094857
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of melatonin effectiveness in the adjuvant treatment of ulcerative colitis.
    Chojnacki C; Wisniewska-Jarosinska M; Walecka-Kapica E; Klupinska G; Jaworek J; Chojnacki J
    J Physiol Pharmacol; 2011 Jun; 62(3):327-34. PubMed ID: 21893693
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Direct comparison of two different mesalamine formulations for the maintenance of remission in patients with ulcerative colitis: a double-blind, randomized study.
    Ito H; Iida M; Matsumoto T; Suzuki Y; Aida Y; Yoshida T; Takano Y; Hibi T
    Inflamm Bowel Dis; 2010 Sep; 16(9):1575-82. PubMed ID: 20049949
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Budesonide Multimatrix Is Efficacious for Mesalamine-refractory, Mild to Moderate Ulcerative Colitis: A Randomised, Placebo-controlled Trial.
    Rubin DT; Cohen RD; Sandborn WJ; Lichtenstein GR; Axler J; Riddell RH; Zhu C; Barrett AC; Bortey E; Forbes WP
    J Crohns Colitis; 2017 Jul; 11(7):785-791. PubMed ID: 28333362
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The efficacy of curcuminoids in improvement of ulcerative colitis symptoms and patients' self-reported well-being: A randomized double-blind controlled trial.
    Masoodi M; Mahdiabadi MA; Mokhtare M; Agah S; Kashani AHF; Rezadoost AM; Sabzikarian M; Talebi A; Sahebkar A
    J Cell Biochem; 2018 Nov; 119(11):9552-9559. PubMed ID: 30132960
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serum 25-hydroxyvitamin D concentration is inversely associated with mucosal inflammation in patients with ulcerative colitis.
    Meckel K; Li YC; Lim J; Kocherginsky M; Weber C; Almoghrabi A; Chen X; Kaboff A; Sadiq F; Hanauer SB; Cohen RD; Kwon J; Rubin DT; Hanan I; Sakuraba A; Yen E; Bissonnette M; Pekow J
    Am J Clin Nutr; 2016 Jul; 104(1):113-20. PubMed ID: 27281309
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The role of centralized reading of endoscopy in a randomized controlled trial of mesalamine for ulcerative colitis.
    Feagan BG; Sandborn WJ; D'Haens G; Pola S; McDonald JWD; Rutgeerts P; Munkholm P; Mittmann U; King D; Wong CJ; Zou G; Donner A; Shackelton LM; Gilgen D; Nelson S; Vandervoort MK; Fahmy M; Loftus EV; Panaccione R; Travis SP; Van Assche GA; Vermeire S; Levesque BG
    Gastroenterology; 2013 Jul; 145(1):149-157.e2. PubMed ID: 23528626
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-term safety and tolerability of once-daily mesalamine granules in the maintenance of remission of ulcerative colitis.
    Lichtenstein GR; Barrett AC; Bortey E; Paterson C; Forbes WP
    Inflamm Bowel Dis; 2014 Aug; 20(8):1399-406. PubMed ID: 24874460
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy of topical versus oral 5-aminosalicylate for treatment of 2,4,6-trinitrobenzene sulfonic acid-induced ulcerative colitis in rats.
    Li J; Chen C; Cao XN; Wang GH; Hu JB; Wang J
    J Huazhong Univ Sci Technolog Med Sci; 2014 Feb; 34(1):59-65. PubMed ID: 24496680
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.